3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
5
Multiple Myeloma
4
Barrett Esophagus
3
Venous Thromboembolism
2
Tobacco Use Disorder
2
Prostatic Neoplasms
2
Precancerous Conditions
2
Polycythemia Vera
2
Myocardial Infarction
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Vascular Diseases
1
Triple Negative Breast Neoplasms
1
Thromboembolism
1
Thrombocytopenia
1
Thrombocythemia, Essential
1
Stroke
1
Soft Tissue Neoplasms
1
Smoking Cessation
1
Sarcoma
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Node Positive HER2 Negative Breast Cancer
1
Neoplasms, Plasma Cell
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myocardial Ischemia
1
Myeloproliferative Disorders
1
Multiple Pulmonary Nodules
1
Interventions
Nutrition Assessment
2
Fatty Acids, Omega-3
2
Vorinostat
1
Vitamin E
1
Tumor Necrosis Factor Inhibitors
1
Therapeutics
1
Sugars
1
Rosuvastatin Calcium
1
Resistance Training
1
Omeprazole
1
Naproxen
1
Methods
1
Liraglutide
1
Jogging
1
Geritol
1
Fish Oils
1
Febuxostat
1
Desvenlafaxine Succinate
1
Colchicine
1
Cholecalciferol
1
Chocolate
1
Bortezomib
1
Atorvastatin
1
Aspirin
1
Antirheumatic Agents
1
Allopurinol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Cardiovascular Diseases
×
Aspirin
×
Clear all
NCT00000479
2012-06-15
WHS
Brigham and Women's Hospital
Phase 3
Completed
39,876 enrolled
11 charts